Landmark-based low implantation using a balloon-expandable valve to avoid sinus sequestration during redo transcatheter aortic valve implantation: a case report

Clicks: 15
ID: 329551
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #262 of 408 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 408 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Redo transcatheter aortic valve implantation (TAVI) is increasingly performed for structural valve deterioration of transcatheter heart valves. Sinus sequestration is a mechanism of coronary obstruction in which displaced leaflets of the index transcatheter valve isolate the coronary sinus from the aortic root after redo TAVI. Case summary An 82-year-old woman presented with dyspnea due to structural valve deterioration 5 years after implantation of a 23-mm SAPIEN 3 (Edwards Lifesciences, Irvine, CA, USA) valve. Computed tomography demonstrated bilateral high-risk anatomy for sinus sequestration during redo TAVI. Coronary ostia and the sinotubular junction were located below the estimated neo-skirt plane. The virtual transcatheter valve-to-sinotubular junction distance was 0 mm, and the virtual transcatheter valve-to-coronary distances were 3.7 mm and 4.7 mm for the right and left coronary arteries, respectively. To preserve residual sinus space, a landmark-based low implantation strategy was planned using the lower border of the uppermost cell of the index SAPIEN 3 valve as a fluoroscopic landmark. A second 20-mm SAPIEN 3 Ultra RESILIA (Edwards Lifesciences, Irvine, CA, USA) valve was implanted with its upper edge aligned to this landmark. Final angiography demonstrated preserved coronary flow without sinus sequestration, and intravascular ultrasound confirmed preserved sinus space outside the displaced leaflet complex in both coronary sinuses. No conduction disturbances or procedural complications occurred. Discussion Landmark-based low implantation using the uppermost cell of the index transcatheter valve may represent a useful strategy to preserve sinus flow and avoid sinus sequestration during redo TAVI in selected high-risk anatomies.
Reference Key
openalex_W7214067680 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag724
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.